ARTICLE | Company News
Alpine Biosciences, Oncothyreon deal
September 15, 2014 7:00 AM UTC
Oncothyreon acquired drug delivery company Alpine for 9.2 million Oncothyreon shares, or about $27.1 million based on Oncothyreon's close of $2.93 on Aug. 8, before the deal was announced. Alpine is d...